Pasar al contenido principal

NUEVAS ESTRATEGIAS PARA TERAPIAS ANTICANCER Y CONTRA EL COVID-19 BASADAS EN HERRAMIENTAS METALOPEPTIDICAS

PID2021-127857NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDADE DE SANTIAGO DE COMPOSTELA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Copper(II) Cyclopeptides with High ROS-Mediated Cytotoxicity

  • Boga, Sonia
  • Bouzada Reboredo, David
  • López-Blanco, Roi
  • Sarmiento Fuentes, Axel
  • Salvadó, Iria
  • Alvar Gil, David
  • Brea Floriani, José Manuel
  • Loza García, María Isabel
  • Barreiro Piñeiro, Natalia
  • Martínez Costas, José Manuel
  • Mena, Silvia
  • Guirado, Gonzalo
  • Santoro, Alice
  • Faller, Peter
  • Vázquez Sentís, Marco Eugenio
  • Vázquez López, Miguel
Cu(II) coordination complexes are emerging as promising anticancer agents due to their ability to induce oxidative stress through reactive oxygen species (ROS) generation. In this study, we synthesized and characterized two novel Cu(II) metallopeptide systems, 1/Cu(II) and 2/Cu(II), derived from the oligocationic bipyridyl cyclopeptides 1 and 2, and designed to enhance the transport of Cu(II) into cells and increase ROS levels. Spectroscopic and electrochemical analyses confirmed the formation of stable metallopeptide species in aqueous media. Inductively coupled plasma mass spectrometry (ICP-MS) studies demonstrated that both metallopeptides significantly increase intracellular Cu(II) accumulation in NCI/ADR-RES cancer cells, highlighting their role as efficient Cu(II) transporters. Additionally, ROS generation assays revealed that 1/Cu(II) induces a substantial increase in intracellular ROS levels, supporting the hypothesis of oxidative stress-induced cytotoxicity. Cell-viability assays further confirmed that both 1/Cu(II) and 2/Cu(II) exhibit strong anticancer activity in a number of cancer cell lines, with IC50 values significantly lower than those of their free cyclopeptide counterparts or Cu(II) alone, showing an order of activity higher than that of cisplatin. Finally, molecular modeling studies provided further insights into the structural stability and coordination environment of Cu(II) within the metallopeptide complexes. These findings suggest that these Cu(II) cyclometallopeptide systems hold potential as novel metal-based therapeutic agents, leveraging Cu(II) transport and ROS increase as key strategies for cancer treatment.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

A copper(II) peptide helicate selectively cleaves DNA replication foci in mammalian cells

  • Alcalde Ordóñez, Ana
  • Barreiro Piñeiro, Natalia
  • McGorman, Brionna
  • Gómez González, Jacobo
  • Bouzada Reboredo, David
  • Rivadulla Fernández, José Francisco
  • Vázquez Sentís, Marco Eugenio
  • Kellet, Andrew
  • Martínez Costas, José Manuel
  • Vázquez López, Miguel
The use of copper-based artificial nucleases as potential anticancer agents has been hampered by their poor selectivity in the oxidative DNA cleavage process. An alternative strategy to solve this problem is to design systems capable of selectively damaging noncanonical DNA structures that play crucial roles in the cell cycle. We designed an oligocationic CuII peptide helicate that selectively binds and cleaves DNA three-way junctions (3WJs) and induces oxidative DNA damage via a ROS-mediated pathway both in vitro and in cellulo, specifically at DNA replication foci of the cell nucleus, where this DNA structure is transiently generated. To our knowledge, this is the first example of a targeted chemical nuclease that can discriminate with high selectivity 3WJs from other forms of DNA both in vitro and in mammalian cells. Since the DNA replication process is deregulated in cancer cells, this approach may pave the way for the development of a new class of anticancer agents based on copper-based artificial nucleases
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Single-ion magnetism in novel Btp-based cobalt complexes of different charge

  • Rama Martínez, Gustavo
  • Osorio-Celis, Marcelo
  • Sabater-Algarra, Yolanda
  • Sánchez-Brunete, Diego
  • Llamas-Saiz, Antonio L.
  • Quirós-Díez, Eugenia P.
  • Vázquez Sentís, Marco Eugenio
  • Vázquez López, Miguel
  • Giménez López, María del Carmen
The magnetic behavior of single-ion metal complexes may be influenced by the nature and composition of the secondary coordination sphere that can be composed of solvent molecules and counterions bound through non-covalent interactions. However, achieving precise control over the outer-coordination sphere of these magnetic complexes to demonstrate its influence on their magnetic properties presents a challenge. A strategy for varying the number of counterions, while simultaneously preserving the arrangement of the ligand atoms around the metal center without altering its oxidation state, is to adjust the overall formal charge of the complex. This adjustment could lead to changes in the magnetic properties of single-ion metal complexes. In this study, we present two novel ligands featuring the coordinating unit Btp (2,6-bis(1,2,3-triazol-4-yl)pyridine). These ligands are equipped with functional groups that can potentially undergo deprotonation. By carefully selecting the solvents used during the crystallization process of the complexes, we can tune at will the charge of the complexes, thus modifying the composition of the CoII complexes’ outer-coordination sphere. We show that, by modifying these conditions, we can tailor the secondary coordination sphere of both charged (mono- and dicationic) and neutral anisotropic CoII metal complexes to show field-induced single-ion magnetism, influencing in turn the size of the barrier to reversal of the magnetization and their slow relaxation process.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Unlocking a biological interface of chiral supramolecular helical polymers

  • Alcalde Ordóñez, Ana
  • Sarmiento Fuentes, Axel
  • Gómez González, Jacobo
  • Bouzada Reboredo, David
  • Núñez Martínez, Manuel
  • Fernández Míguez, Manuel
  • Rodríguez Riego, Rafael
  • Freire Iribarne, Félix Manuel
  • Vázquez Sentís, Marco Eugenio
  • Vázquez López, Miguel
Here we report a C3-symmetric metal-binding tripeptide, BTMA-1, that self-assembles in water into either a chiral supramolecular helical polymer or a discrete CoII peptide helicate, depending on metal coordination. The CoII peptide helicate exhibits high affinity and selectivity toward DNA three-way junctions (3WJ), a class of noncanonical DNA structures with emerging biological relevance. Importantly, we demonstrate that the recognition process can be triggered dynamically by adding CoII ions to a dispersion of the supramolecular polymer, which acts as an inert precursor reservoir in physiological media. In this way, our strategy shows that chiral supramolecular helical polymers can form temporarily inactive aggregates that release discrete helicates for biomolecular recognition, such as 3WJ binding, upon metal ion coordination. Overall, this mechanism reveals a previously unexplored capability of this class of materials and offers a new approach for the design of responsive supramolecular systems for nucleic acid recognition and anticancer therapy.